Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 3Terminated 2Not yet recruiting 2Unknown 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomach Neoplasms 3Carcinoma, Transitional Cell 2Breast Neoplasms 2Thyroid Diseases 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Parathyroid Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Lung Neoplasms 1Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Castration-Resistant Prostate Cancer (CRPC) 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Enrolling by invitation × Small Cell Lung Carcinoma × Clear all
NCT06747832 2024-12-24

iNK-SCLC

Guangzhou Ruixin Biotechnological Co., LTD

Phase EARLY_PHASE1 Enrolling by invitation
10 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡